非経口栄養剤の世界市場規模、シェア、成長分析：栄養タイプ別、ステージタイプ別、症状別、販売チャネル別、地域別 - 産業予測（2024年～2031年）

世界の非経口栄養剤の市場規模は、2022年に67億米ドルとなり、予測期間（2024年～2031年）のCAGRは6.0%で、2023年の71億米ドルから2031年には114億米ドルに成長する見通しです。

世界の非経口栄養剤市場は、栄養失調のリスクを抱える高齢者人口の拡大とともに、がんや胃腸障害などの慢性疾患の増加によって、継続的な成長が見込まれています。カスタマイズ可能な栄養素の組み合わせを提供するマルチチャンバーバッグを含む非経口栄養剤製剤の最近の進歩は、患者のケアと投与の容易さを向上させています。しかし、市場は、長期療法に伴う感染リスク、製品や機器の高コスト、特に新興地域においてアクセシビリティを制限する規制上のハードルといった課題に直面しています。厳格な感染対策、専門的な製造、標準化されたガイドラインの必要性が市場力学を複雑にしています。全体として、革新的な製品開発と規制の調和が、これらの課題に対処し市場拡大を支える上で極めて重要となります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 技術の進歩
• 規制情勢
• バリューチェーン分析
• 特許分析
• PESTEL分析
• マクロ経済指標
• 市場の魅力指数

非経口栄養剤市場規模：栄養タイプ別、CAGR（2024年～2031年）

• 市場概要
• 炭水化物
• 非経口脂質乳剤
• 単回投与アミノ酸溶液
• 微量元素
• ビタミンとミネラル

非経口栄養剤市場規模：ステージタイプ別、CAGR（2024年～2031年）

• 市場概要
• 成人
• 小児

非経口栄養剤市場規模：症状別、CAGR（2024年～2031年）

• 市場概要
• アルツハイマー病
• 栄養不足
• がん治療
• 糖尿病
• 慢性腎臓病
• 希少疾患
• 嚥下障害
• 疼痛管理
• 吸収不良/消化管障害/下痢
• その他

非経口栄養剤市場規模：販売チャネル別、CAGR（2024年～2031年）

• 市場概要
• オンライン
• 小売
• 機関

非経口栄養剤市場規模、CAGR（2024年～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比の比較（2021年～2023年）

主要企業プロファイル

• B. Braun Melsungen AG
• Fresenius Kabi AG
• Sichuan Kelun Industrial Group Co Ltd
• Pfizer Inc.
• Baxter International Inc.
• Grifols SA
• Otsuka Holdings Co. Ltd（Otsuka Pharmaceutical Co., Ltd.）
• Nirma Group（Aculife Healthcare Pvt. Ltd.）
• Abbott Laboratories
• Medtronic
• Beximco Pharmaceuticals Ltd.
• Sichuan Luye Pharmaceutical Co., Ltd.
• ICU Medical, Inc.
• JW Pharmaceutical Corporation
• Servona GmbH
• Anhui Medipharm Co., Ltd.
• Nipro Corporation
• Biosyn Arzneimittel
• Terumo Corporation
• Lonza Group

結論と推奨事項

Global Parenteral Nutrition Market size was valued at USD 6.7 billion in 2022 and is poised to grow from USD 7.1 billion in 2023 to USD 11.4 billion by 2031, growing at a CAGR of 6.0% during the forecast period (2024-2031).

The global parenteral nutrition market is poised for continued growth, driven by rising chronic diseases such as cancer and gastrointestinal disorders, alongside an increasing geriatric population at risk of malnutrition. Recent advancements in parenteral nutrition formulations, including multi-chamber bags that offer customizable nutrient combinations, have enhanced patient care and ease of administration. However, the market faces challenges like infection risks associated with long-term therapy, high costs of products and equipment, and regulatory hurdles that can limit accessibility, especially in developing regions. The need for stringent infection control measures, specialized manufacturing, and standardized guidelines complicates market dynamics. Overall, innovative product development and harmonized regulations will be crucial for addressing these challenges and supporting market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Parenteral Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Nutrition Market Segmental Analysis

Global Parenteral Nutrition Market is segmented by Nutrition Type, Stage Type, Indication, Sales Channel and region. Based on Nutrition Type, the market is segmented into Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals. Based on Stage Type, the market is segmented into Adult, Pediatrics. Based on Indication, the market is segmented into Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Disease, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others. Based on Sales Channel, the market is segmented into Online, Retail, and Institutional. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Parenteral Nutrition Market

The global market for parenteral nutrition is significantly driven by technological advancements in product formulations and delivery systems. Innovations in nutrient combinations and formulation techniques have markedly improved the safety and effectiveness of parenteral nutrition therapies. These enhancements not only streamline the administration process for healthcare providers but also increase comfort and tolerance for patients undergoing treatment. As a result, the upgraded products and methods are expanding the reach and application of parenteral nutrition, reinforcing its vital role in supporting patients who cannot receive adequate nutrition through traditional means. Such developments are crucial in meeting the growing demand for specialized nutritional care on a global scale.

Restraints in the Global Parenteral Nutrition Market

The global parenteral nutrition market faces significant restraints, primarily due to regulatory constraints and the absence of standardized protocols. Divergent regulations and inconsistent guidelines for parenteral nutrition therapy in various regions create hurdles for both manufacturers and healthcare professionals. This lack of uniformity can lead to complications in ensuring the safe and effective delivery of parenteral nutrition. To overcome these challenges, it is crucial to establish harmonized regulatory frameworks and develop evidence-based guidelines that can foster consistency and enhance patient care across different geographic locations. Addressing these issues is vital for the growth and stability of the market.

Market Trends of the Global Parenteral Nutrition Market

The Global Parenteral Nutrition market is witnessing a significant trend toward the integration of digital health technologies, including mobile applications, connected devices, and telehealth solutions. This shift facilitates remote monitoring and real-time data collection, which enhances communication between patients, caregivers, and healthcare providers. As a result, healthcare professionals can better manage parenteral nutrition therapy, leading to improved treatment outcomes and patient satisfaction. The increasing focus on personalized medicine and the rising demand for remote healthcare solutions are driving this trend, indicating a robust growth trajectory for the market as technology plays an essential role in optimizing nutritional support.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Value Chain Analysis
• Patent Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Parenteral Nutrition Market Size by Nutrition Type & CAGR (2024-2031)

• Market Overview
• Carbohydrates
• Parenteral Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins & Minerals

Global Parenteral Nutrition Market Size by Stage Type & CAGR (2024-2031)

• Market Overview
• Adult
• Pediatrics

Global Parenteral Nutrition Market Size by Indication & CAGR (2024-2031)

• Market Overview
• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

Global Parenteral Nutrition Market Size by Sales Channel & CAGR (2024-2031)

• Market Overview
• Online
• Retail
• Institutional

Global Parenteral Nutrition Market Size & CAGR (2024-2031)

• North America (Nutrition Type, Stage Type, Indication, Sales Channel)
  • US
  • Canada
• Europe (Nutrition Type, Stage Type, Indication, Sales Channel)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Nutrition Type, Stage Type, Indication, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Nutrition Type, Stage Type, Indication, Sales Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Nutrition Type, Stage Type, Indication, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Kelun Industrial Group Co Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings Co. Ltd (Otsuka Pharmaceutical Co., Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nirma Group (Aculife Healthcare Pvt. Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beximco Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Luye Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Pharmaceutical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Servona GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anhui Medipharm Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosyn Arzneimittel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation